Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-21-006715
Filing Date
2021-06-17
Accepted
2021-06-17 18:51:00
Documents
1
Period of Report
2021-06-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-53151.html 4  
1 PRIMARY DOCUMENT marketforms-53151.xml 4 4668
  Complete submission text file 0001214659-21-006715.txt   6120
Mailing Address C/O BIOENVISION, INC. 345 PARK AVENUE, 41ST. FLOOR NEW YORK NY 10154
Business Address
Scibetta James S (Reporting) CIK: 0001383242 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 211026403

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations